Torrent Pharmaceuticals has completed the acquisition of a 46.39% stake in JB Chemicals & Pharmaceuticals, resulting in a change of control and board reconstitution. Key board members have resigned, and the board has officially recognized Torrent Pharma as the new promoter. The changes follow a share purchase agreement executed in June 2025, marking a significant shift in JB Chemicals’ leadership.
Torrent Pharma Takes Control
Torrent Pharmaceuticals Limited has acquired 7,44,81,519 equity shares representing 46.39% of JB Chemicals & Pharmaceuticals Limited (JB Pharma). The acquisition was completed on January 21, 2026, making Torrent Pharma the new promoter of JB Pharma.
Board Resignations and Reconstitution
Following the change in control, several key members of the board have resigned. Mr. Gaurav Trehan, Mr. Akshay Tanna and Mr. Prashant Kumar, all non-executive, non-independent directors, have stepped down from their positions. Additionally, Mr. Nikhil Chopra has resigned as Whole-time Director, effective immediately, and will step down as CEO on March 31, 2026.
Outgoing Promoter Reclassification
With Torrent Pharma’s acquisition, the previous promoter, Tau Investment Holdings Pte. Ltd., has been reclassified from ‘promoter’ to ‘public’ category, effective January 21, 2026.
Source: BSE
